An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancerDaniel Morgensztern, Pilar Garrido, Enriqueta Felip et al.|Lung Cancer|2019Cited by 24
ADAR1 silencing-induced HUVEC apoptosis is mediated by FGFR2 under hypoxia stressYun Jiang, Xiaowei Wang|Drug Design Development and Therapy|2018Cited by 12